StableLab is the clearest and earliest indicator of equine infections and is used at the horse’s side to take blood and generate results within minutes. This convenient, hand-held reader tests for a new biomarker with lab-accurate readings enabling better management of the horse’s health before, during and after competition.
“California Chrome had a tiny ulcer on his soft palate,” says lead veterinarian Kevin Dunlavy, D.V.M. “Before the Preakness and after the Kentucky Derby, we utilized the StableLab blood test to assess his health. The test showed that he had no other systemic diseases, and we were assured that everything was normal for the champ.”
StableLab works by detecting and measuring Serum Amyloid A (SAA), a major acute phase protein. What makes this biomarker particularly useful in horses is that it responds quickly and aggressively to infections but not to non-infectious conditions – a discovery made and patented by StableLab.
StableLab was introduced in the United States at the American Association of Equine Practitioners convention in December 2013, with endorsement from two of the U.S.’s largest equine hospitals: Hagyard Equine Medical Institute and Rood & Riddle Equine Hospital. StableLab has also worked with WinStar Farm in Kentucky on the use of SAA for disease-screening in foals.